We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+23.01%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$900M
Cap. Flow
+$775M
Cap. Flow %
39.93%
Top 10 Hldgs %
51.62%
Holding
194
New
73
Increased
41
Reduced
31
Closed
42

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Industrials 0.76%
3 Consumer Staples 0.45%
4 Energy 0.25%
5 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$354M 18.25%
1,057,400
+773,400
+272% +$256M
IWM icon
2
PUT
iShares Russell 2000 ETF
IWM
$83B
$179M 9.23%
1,195,000
+578,000
+94% +$87M
XBI icon
3
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$112M 5.76%
1,002,900
+670,900
+202% +$75.2M
QQQ icon
4
PUT
Invesco QQQ Trust
QQQ
$484B
$111M 5.73%
+400,000
New +$108M
XLV icon
5
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$67M 3.45%
635,000
+252,000
+66% +$26.5M
NSTG
6
DELISTED
NanoString Technologies, Inc.
NSTG
$42.8M 2.21%
957,322
-103,409
-10% -$4.02M
IBB icon
7
PUT
iShares Biotechnology ETF
IBB
$9.77B
$37.4M 1.93%
+276,500
New +$37.5M
FXH icon
8
PUT
First Trust Health Care AlphaDEX Fund
FXH
$1.08B
$34.8M 1.79%
367,500
+265,500
+260% +$24.9M
INSP icon
9
Inspire Medical Systems
INSP
$1.74B
$33.5M 1.73%
259,806
-77,210
-23% -$8.51M
INOV
10
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$30M 1.54%
1,132,707
+85,491
+8% +$2M
ICUI icon
11
ICU Medical
ICUI
$4.61B
$29.8M 1.54%
162,999
+28,748
+21% +$5.41M
STAA icon
12
STAAR Surgical
STAA
$1.21B
$28.3M 1.46%
500,000
+142,220
+40% +$7.66M
COO icon
13
Cooper Companies
COO
$14.5B
$27M 1.39%
+320,000
New +$24.5M
ATRC icon
14
AtriCure
ATRC
$2.11B
$25.7M 1.33%
645,003
-40,270
-6% -$1.71M
VRAY
15
DELISTED
ViewRay, Inc.
VRAY
$24.4M 1.26%
6,981,137
+138,183
+2% +$385K
MDT icon
16
CALL
Medtronic
MDT
$112B
$22.9M 1.18%
+220,000
New +$22.1M
ALXN
17
DELISTED
Alexion Pharmaceuticals
ALXN
$22.5M 1.16%
196,296
-8,400
-4% -$906K
PPD
18
DELISTED
PPD, Inc. Common Stock
PPD
$22.2M 1.14%
+600,000
New +$19M
ESTA icon
19
Establishment Labs
ESTA
$2.28B
$22.1M 1.14%
1,195,284
+250,326
+26% +$4.45M
DXCM icon
20
PUT
DexCom
DXCM
$32B
$17.3M 0.89%
+168,000
New +$17.6M
OM icon
21
Outset Medical
OM
$90.8M
$17M 0.88%
+22,667
New +$18.6M
VCEL icon
22
Vericel Corp
VCEL
$2.31B
$16.7M 0.86%
+899,857
New +$14.9M
AFIB
23
DELISTED
Acutus Medical Inc
AFIB
$15.9M 0.82%
+534,998
New +$16.2M
QTNT
24
DELISTED
Quotient Limited Ordinary Shares
QTNT
$15.7M 0.81%
76,372
+44,611
+140% +$11.6M
CNMD icon
25
CONMED
CNMD
$1.47B
$15.7M 0.81%
199,002
+89,102
+81% +$7.27M

Similar funds

Pura Vida Investments's Q3 2020 Portfolio in Review

As of Q3 2020, Pura Vida Investments held 194 positions worth $1.94B, up 87% from $1.04B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Pura Vida Investments deployed $775M of net new capital in Q3 2020, opening 73 new positions and adding to 41 existing holdings. Its largest new stake was Cooper Companies: 320,000 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 38% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was LHC Group LLC, an estimated $8.66M trimmed.

  • Pura Vida Investments's largest Q3 2020 buy was Cooper Companies: 320,000 shares worth $27M.
  • Pura Vida Investments added most to Quotient Limited Ordinary Shares in Q3 2020, an estimated $11.6M increase.
  • Pura Vida Investments's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $8.66M.
  • Pura Vida Investments fully exited LivaNova in Q3 2020, selling an estimated $7.29M.
  • Pura Vida Investments's ten largest holdings make up 52% of its $1.94B portfolio in Q3 2020.
  • Pura Vida Investments opened 73 new positions and closed 42 in Q3 2020.
  • Pura Vida Investments's portfolio value rose 87% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q3 2020, filed 16 Nov 2020.